当前位置: X-MOL 学术Comput. Struct. Biotechnol. J. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The Glu102 mutation disrupts higher-order oligomerization of the sigma 1 receptor.
Computational and Structural Biotechnology Journal ( IF 6 ) Pub Date : 2020-01-07 , DOI: 10.1016/j.csbj.2019.12.012
Ara M Abramyan 1 , Hideaki Yano 1 , Min Xu 1 , Leanne Liu 1 , Sett Naing 1 , Andrew D Fant 1 , Lei Shi 1
Affiliation  

The sigma 1 receptor (σ1R) is a unique endoplasmic reticulum membrane protein. Its ligands have been shown to possess therapeutic potential for neurological and substance use disorders among others. The E102Q mutation of σ1R has been found to elicit familial cases of amyotrophic lateral sclerosis (ALS). Despite reports of its downstream signaling consequences, the mechanistic details of the functional impact of E102Q at molecular level are not clear. Here, we investigate the molecular mechanism of the E102Q mutation with a spectrum of biochemical, biophysical, and pharmacological approaches. Our analysis of the interaction network of σ1R indicates that a set of residues near E102 is critical for the integrity of C-terminal ligand-binding domain. However, this integrity is not affected by the E102Q and E102A mutations, which is confirmed by the radioligand binding results. Instead, the E102 mutations disrupt the connection between the C-terminal domain and the N-terminal transmembrane helix (NT-helix). Results from bioluminescence resonance energy transfer and western blot assays demonstrate that these mutations destabilize higher-order σ1R oligomers, while our molecular dynamics simulations based on a σ1R crystal structure reveal a potential mechanism by which the mutations perturb the NT-helix dynamics. Thus, we propose that E102 is at a critical position in propagating the effects of ligand binding from the C-terminal domain to the NT-helix, while the latter may be involved in forming alternative oligomer interfaces, separate from the previously reported trimer interface. Together, these results provide the first account of the molecular mechanism of σ1R dysfunction caused by E102Q.



中文翻译:

Glu102突变破坏sigma 1受体的高阶寡聚。

σ1受体(σ1R)是一种独特的内质网膜蛋白。已经显示出其配体具有治疗神经系统疾病和物质使用疾病的潜力。已经发现σ1R的E102Q突变引起肌萎缩性侧索硬化症(ALS)的家族病例。尽管报告了其下游信号传导后果,但尚不清楚E102Q在分子水平上的功能影响的机制细节。在这里,我们用一系列生化,生物物理和药理学方法研究了E102Q突变的分子机制。我们对σ1R相互作用网络的分析表明,E102附近的一组残基对于C端配体结合域的完整性至关重要。但是,这种完整性不受E102Q和E102A突变的影响,放射性配体结合结果证实了这一点。相反,E102突变破坏了C端结构域和N端跨膜螺旋(NT-螺旋)之间的连接。生物发光共振能量转移和蛋白质印迹分析的结果表明,这些突变使高阶σ1R低聚物不稳定,而我们基于σ1R晶体结构的分子动力学模拟揭示了潜在的机制,该突变可干扰NT螺旋动力学。因此,我们提出E102在从C-末端结构域到NT-螺旋的配体结合作用的传播中处于关键位置,而后者可能参与形成替代的低聚物界面,与先前报道的三聚体界面分开。一起,

更新日期:2020-01-07
down
wechat
bug